FDA Approves Blood Test Which May Let Some Cancer Patients Avoid Additional Biopsies

Published Aug 29, 2020

FDA Approves Blood Test Which May Let Some Cancer Patients Avoid Additional Biopsies

Foundation Medicine just got the green light from the Food and Drug Administration (FDA) to launch a new blood test which could eliminate the fuss of additional biopsies and determine treatment faster.

NOW
PLAYING
The FDA Expedites the Development of New Prostate Cancer Drug
NOW
PLAYING
FDA Approves First Targeted Therapy For Lung Cancer Patients With the KRAS Gene Mutation
NOW
PLAYING
Delayed Cancer Screenings Due to COVID: What to Do Now
NOW
PLAYING
All Americans Should Begin Colorectal Cancer Screening at Age 45, According to New Guidelines; Previous Age Was 50
NOW
PLAYING
Cancer Patients Should Still Wear Masks & Distance Says Leading Expert - Even in Wake of Major New CDC Guidelines
NOW
PLAYING
Recent Study Reveals Nearly 10 Million Cancer Screenings Were Skipped During COVID-19; Don't Miss These Life-Saving Resources

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.